Comparison of the Effects of Kinesio Taping and Compression Bandaging on Edema, Range of Motion, Upper Extremity Function, and Grip Strength in Patients With Breast Cancer-Related Lymphedema
This randomized crossover clinical trial aims to compare the effects of Kinesio Taping and compression bandaging on upper extremity edema, shoulder range of motion, upper extremity function, pain, and grip strength in patients with breast cancer-related lymphedema.
A total of 44 participants will receive both treatment approaches in different sequences. Each intervention period will last 4 weeks, with a 2-week washout period between treatments. Manual lymphatic drainage will be applied three times per week during the intervention periods. Assessments will be performed at baseline, week 4, and week 10.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Detaillierte Beschreibung
This randomized crossover clinical trial was designed to compare the effects of Kinesio Taping and compression bandaging on upper extremity edema, shoulder range of motion, upper extremity function, pain, and grip strength in patients with breast cancer-related lymphedema.
A total of 44 participants will be randomly allocated to one of two treatment sequences. In the first 4-week treatment period, one group will receive Kinesio Taping combined with manual lymphatic drainage, while the other group will receive compression bandaging combined with manual lymphatic drainage. Manual lymphatic drainage will be administered three times per week during the intervention periods.
After completion of the first 4-week treatment period, a 2-week washout period will be implemented. Following the washout period, participants will cross over to the alternative intervention for an additional 4 weeks. Participants who initially received Kinesio Taping will subsequently receive compression bandaging, whereas participants who initially received compression bandaging will subsequently receive Kinesio Taping.
Clinical assessments will be performed at baseline, at the end of the first treatment period (week 4), and at the end of the second treatment period (week 10). Upper extremity edema, shoulder range of motion, upper extremity function, pain, and grip strength will be evaluated at these time points.
The crossover design allows all participants to receive both therapeutic interventions and enables within-participant comparison of the effects of Kinesio Taping and compression bandaging. The 2-week washout period is included to reduce potential carryover effects from the first treatment period before initiation of the second intervention.
Studientyp
Studientyp
Einschreibung (Geschätzt)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Bakırköy
-
Istanbul, Bakırköy, Türkei (türkiye), 34149
- Istanbul University Cerrahpaşa Faculty of Medicine Hospital
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Diagnosis of lymphedema following breast cancer treatment (confirmed by clinical evaluation or objective measurements).
- Age between 18 and 75 years (adult participants will be included).
- Willingness to participate voluntarily in the study and provision of written informed consent.
- Unilateral lymphedema (to ensure standardization of assessments).
- Lymphedema in the chronic stage (present for more than 3 months).
- A stable condition in terms of lymphedema treatment (no other lymphedema treatment received within the last month).
- Sufficient functional capacity to complete physical assessments and measurements (movement limitations should not be at a level that prevents evaluation).
Exclusion Criteria:
- History of advanced-stage cancer or active metastatic disease.
- Presence of severe cardiovascular or respiratory disease (e.g., heart failure, chronic obstructive pulmonary disease).
- History of diabetic neuropathy or peripheral vascular disease (may affect lymphedema management due to circulatory impairment).
- Presence of severe skin reactions or dermatological conditions (that compromise skin integrity and prevent tape application).
- Pregnancy or breastfeeding.
- History of allergic reactions to kinesio tape or compression bandages.
- History of lymphatic drainage surgery or other surgical intervention within the past 6 months.
- Diagnosis of bilateral lymphedema (only unilateral cases will be included to standardize the assessment process).
- Inability to actively participate in the study due to mental or cognitive impairment.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Crossover-Aufgabe
- Maskierung: Keine (Offenes Etikett)
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Experimental: Kinesiotaping Group
Patients with lymphedema who will receive kinesio taping treatment first, followed by compression bandaging. |
MLD will accompany both groups throughout the intervention periods. MLD sessions will be administered by a trained physiotherapist three times per week for a total duration of 4 weeks in each treatment period. Kinesio taping: This technique will be applied to the edematous extremity in accordance with lymphatic drainage directions, three times per week. The tapes will remain in place for 2-3 days at each application. Compression bandaging: Multi-layer, short-stretch compression bandages will be reapplied after each MLD session (three times per week). Due to the crossover design of the study, the applied interventions will be switched between groups after the initial 4-week treatment period. Prior to the second intervention phase, a 1-week washout period will be implemented to minimize potential carryover effects from the previous treatment. No treatment will be administered during this washout period. |
|
Experimental: Compression Bandaging
Patients with lymphedema who will receive compression bandaging first, followed by kinesio taping treatment. |
MLD will accompany both groups throughout the intervention periods. MLD sessions will be administered by a trained physiotherapist three times per week for a total duration of 4 weeks in each treatment period. Kinesio taping: This technique will be applied to the edematous extremity in accordance with lymphatic drainage directions, three times per week. The tapes will remain in place for 2-3 days at each application. Compression bandaging: Multi-layer, short-stretch compression bandages will be reapplied after each MLD session (three times per week). Due to the crossover design of the study, the applied interventions will be switched between groups after the initial 4-week treatment period. Prior to the second intervention phase, a 1-week washout period will be implemented to minimize potential carryover effects from the previous treatment. No treatment will be administered during this washout period. |
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Upper Extremity Edema
Zeitfenster: The assessment measurements will be conducted before the initiation of treatment, after 4 weeks, and at week 10.
|
Arm circumference measurement was used as an objective indicator of lymphedema severity. Circumferential measurements were obtained using a non-elastic tape measure at standardized anatomical landmarks along the upper extremity. Measurements were taken at fixed intervals (e.g., every 5 cm) starting from the wrist and progressing proximally toward the elbow and upper arm. Values were recorded in millimeters (mm), with higher circumference values indicating greater edema severity. There is no predefined upper limit for arm circumference; therefore, larger measurements reflect increased fluid accumulation, whereas smaller values indicate reduced edema. To quantify lymphedema, the difference in circumference between the affected and unaffected extremities was calculated at each measurement point. A greater inter-limb difference represents more severe lymphedema, while a reduction in this difference over time indicates clinical improvement. |
The assessment measurements will be conducted before the initiation of treatment, after 4 weeks, and at week 10.
|
|
Change in Pain Intensity
Zeitfenster: The assessment measurements will be conducted before the initiation of treatment, after 4 weeks, and at week 10.
|
The Visual Analog Scale (VAS) is a 10-centimeter horizontal line used to assess pain intensity. Scores range from 0 to 10, where 0 indicates no pain and 10 indicates worst imaginable pain. Higher scores indicate greater pain severity. |
The assessment measurements will be conducted before the initiation of treatment, after 4 weeks, and at week 10.
|
|
Change in Shoulder Range of Motion
Zeitfenster: The assessment measurements will be conducted before the initiation of treatment, after 4 weeks, and at week 10.
|
Joint range of motion (ROM) was assessed to evaluate upper-extremity mobility in individuals with lymphedema. Active ROM measurements were obtained using a standard universal goniometer based on anatomical landmarks. Measurements were recorded in degrees (°) for wrist, elbow, forearm, and shoulder movements. Higher ROM values indicate greater joint mobility and better functional status, whereas lower values reflect movement limitation. As ROM does not have a single fixed maximum value, results were interpreted relative to anatomical normative values and the contralateral limb. A reduction of ≥10° compared with the unaffected side was considered a clinically meaningful limitation, while an increase toward normal values over time was interpreted as a positive treatment response. Each movement was measured three times, and the mean value was used for analysis. ROM assessments were performed at baseline and after each intervention period. |
The assessment measurements will be conducted before the initiation of treatment, after 4 weeks, and at week 10.
|
|
Change in Upper Extremity Function
Zeitfenster: The assessment measurements will be conducted before the initiation of treatment, after 4 weeks, and at week 10.
|
Upper-extremity functioning was assessed using the Disabilities of the Arm, Shoulder and Hand (QuickDASH) Functioning Scale, a self-reported questionnaire designed to evaluate physical function and symptoms related to upper-limb disorders. The QuickDASH consists of 30 items, each scored on a 5-point Likert scale ranging from 1 (no difficulty) to 5 (unable to perform or extreme difficulty). Item scores are combined and transformed into a total score ranging from 0 to 100, where 0 indicates no disability and 100 represents the most severe functional limitation. Higher scores therefore reflect worse upper-extremity functioning and greater disability. A decrease in QuickDASH score over time indicates functional improvement, whereas an increase reflects worsening functional status. The QuickDASH has no absolute clinical cut-off; however, changes of 10-15 points are generally considered clinically meaningful. |
The assessment measurements will be conducted before the initiation of treatment, after 4 weeks, and at week 10.
|
|
Change in Grip Strength
Zeitfenster: The assessment measurements will be conducted before the initiation of treatment, after 4 weeks, and at week 10.
|
Grip strength was assessed using a Jamar hand dynamometer, a widely accepted and reliable instrument for measuring isometric hand grip strength in clinical and research settings. Measurements were recorded in kilograms (kg), with higher values indicating greater muscle strength and better functional capacity, and lower values reflecting reduced grip strength. Participants were seated in a standardized position with the shoulder adducted and neutrally rotated, the elbow flexed at 90 degrees, the forearm in a neutral position, and the wrist positioned between 0-30° extension and 0-15° ulnar deviation. Participants were instructed to squeeze the dynamometer with maximal effort for a few seconds. Each hand was tested three times, with adequate rest between trials to minimize fatigue, and the mean value was used for analysis. |
The assessment measurements will be conducted before the initiation of treatment, after 4 weeks, and at week 10.
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Ermittler
Ermittler
- Studienleiter: Seda Yildiz, PhD, Halic University
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S240-52. doi: 10.1002/acr.20543. No abstract available.
- Beaton DE, Wright JG, Katz JN; Upper Extremity Collaborative Group. Development of the QuickDASH: comparison of three item-reduction approaches. J Bone Joint Surg Am. 2005 May;87(5):1038-46. doi: 10.2106/JBJS.D.02060.
- Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010 Jun;17(6):1471-4. doi: 10.1245/s10434-010-0985-4.
- Bijur PE, Silver W, Gallagher EJ. Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med. 2001 Dec;8(12):1153-7. doi: 10.1111/j.1553-2712.2001.tb01132.x.
- Lasinski BB, McKillip Thrift K, Squire D, Austin MK, Smith KM, Wanchai A, Green JM, Stewart BR, Cormier JN, Armer JM. A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. PM R. 2012 Aug;4(8):580-601. doi: 10.1016/j.pmrj.2012.05.003.
- Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin. 2017 Mar;67(2):93-99. doi: 10.3322/caac.21388. Epub 2017 Jan 17.
- Kilbreath SL, Perkins S, Crosbie J, McConnell J. Gluteal taping improves hip extension during stance phase of walking following stroke. Aust J Physiother. 2006;52(1):53-6. doi: 10.1016/s0004-9514(06)70062-9.
- Thelen MD, Dauber JA, Stoneman PD. The clinical efficacy of kinesio tape for shoulder pain: a randomized, double-blinded, clinical trial. J Orthop Sports Phys Ther. 2008 Jul;38(7):389-95. doi: 10.2519/jospt.2008.2791. Epub 2008 May 29.
- Executive Committee of the International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology. Lymphology. 2020;53(1):3-19.
- Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993 Dec;2(6):335-9; discussion 340. doi: 10.1016/0960-7404(93)90064-6.
- Mostafavifar M, Wertz J, Borchers J. A systematic review of the effectiveness of kinesio taping for musculoskeletal injury. Phys Sportsmed. 2012 Nov;40(4):33-40. doi: 10.3810/psm.2012.11.1986.
- Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG). Am J Ind Med. 1996 Jun;29(6):602-8. doi: 10.1002/(SICI)1097-0274(199606)29:63.0.CO;2-L.
- Kalron A, Bar-Sela S. A systematic review of the effectiveness of Kinesio Taping--fact or fashion? Eur J Phys Rehabil Med. 2013 Oct;49(5):699-709. Epub 2013 Apr 5.
- Zuther, J. E. (2013). Lymphedema Management: The Comprehensive Guide for Practitioners (3rd ed.). Thieme Medical Publishers.
- Selcuk Yilmaz S, Ayhan FF. The Randomized Controlled Study of Low-Level Laser Therapy, Kinesio-Taping and Manual Lymphatic Drainage in Patients With Stage II Breast Cancer-Related Lymphedema. Eur J Breast Health. 2023 Jan 1;19(1):34-44. doi: 10.4274/ejbh.galenos.2022.2022-6-4. eCollection 2023 Jan.
- Yang, J., & Lim, E. J. (2023). A Systematic Review of Kinesiology Taping in Patients With Lymphedema. Physical Therapy Korea, 30(4), 288-305.
- Vignes S, Porcher R, Arrault M, Dupuy A. Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy. Breast Cancer Res Treat. 2007 Mar;101(3):285-90. doi: 10.1007/s10549-006-9297-6. Epub 2006 Jul 7.
- Tsai HJ, Hung HC, Yang JL, Huang CS, Tsauo JY. Could Kinesio tape replace the bandage in decongestive lymphatic therapy for breast-cancer-related lymphedema? A pilot study. Support Care Cancer. 2009 Nov;17(11):1353-60. doi: 10.1007/s00520-009-0592-8. Epub 2009 Feb 8.
- Torres-Lacomba M, Navarro-Brazalez B, Prieto-Gomez V, Ferrandez JC, Bouchet JY, Romay-Barrero H. Effectiveness of four types of bandages and kinesio-tape for treating breast-cancer-related lymphoedema: a randomized, single-blind, clinical trial. Clin Rehabil. 2020 Sep;34(9):1230-1241. doi: 10.1177/0269215520935943. Epub 2020 Jun 24.
- Thomaz JP, Dias TDSM, de Rezende LF. Effect of taping as treatment to reduce breast cancer lymphedema: literature review. J Vasc Bras. 2018 Apr-Jun;17(2):136-140. doi: 10.1590/1677-5449.007217.
- Tidhar D, Katz-Leurer M. Aqua lymphatic therapy in women who suffer from breast cancer treatment-related lymphedema: a randomized controlled study. Support Care Cancer. 2010 Mar;18(3):383-92. doi: 10.1007/s00520-009-0669-4. Epub 2009 Jun 3.
- Taradaj J, Halski T, Zdunczyk M, Rajfur J, Pasternok M, Chmielewska D, Piecha M, Kwasna K, Skrzypulec-Plinta V. Evaluation of the effectiveness of kinesio taping application in a patient with secondary lymphedema in breast cancer: a case report. Prz Menopauzalny. 2014 Mar;13(1):73-7. doi: 10.5114/pm.2014.41082. Epub 2014 Mar 10.
- Stanton AW, Northfield JW, Holroyd B, Mortimer PS, Levick JR. Validation of an optoelectronic limb volumeter (Perometer). Lymphology. 1997 Jun;30(2):77-97.
- Smykla A, Walewicz K, Trybulski R, Halski T, Kucharzewski M, Kucio C, Mikusek W, Klakla K, Taradaj J. Effect of Kinesiology Taping on breast cancer-related lymphedema: a randomized single-blind controlled pilot study. Biomed Res Int. 2013;2013:767106. doi: 10.1155/2013/767106. Epub 2013 Nov 27.
- Sibbald, B., Roberts, C., & Moore, L. (2019). Principles of randomised controlled trials. In J. M. Bland (Ed.), An Introduction to Medical Statistics (4th ed., pp. 123-140). Oxford University Press.
- Pekyavas NO, Tunay VB, Akbayrak T, Kaya S, Karatas M. Complex decongestive therapy and taping for patients with postmastectomy lymphedema: a randomized controlled study. Eur J Oncol Nurs. 2014 Dec;18(6):585-90. doi: 10.1016/j.ejon.2014.06.010. Epub 2014 Jul 21.
- Opuchlik, A. M., Biskup, M., Solakiewicz, M., Kamińska-Gwóźdź, E., Ridan, T., Włoch, A., & Lipińska, A. M. (2014). A comparison of the effect of the application of kinesiology taping to the use of upper limb compression products in the second phase of treating lymphoedema in patients after mastectomy. Medical Studies/Studia Medyczne, 30(3), 188-195.
- Norkin, C. C., & White, D. J. (2016). Measurement of joint motion: A guide to goniometry (5th ed.). F.A. Davis Company.
- Melgaard D. What is the effect of treating secondary lymphedema after breast cancer with complete decongestive physiotherapy when the bandage is replaced with Kinesio Textape? - A pilot study. Physiother Theory Pract. 2016 Aug;32(6):446-451. doi: 10.3109/09593985.2016.1143541. Epub 2016 Jun 3.
- Malicka I, Rosseger A, Hanuszkiewicz J, Wozniewski M. Kinesiology Taping reduces lymphedema of the upper extremity in women after breast cancer treatment: a pilot study. Prz Menopauzalny. 2014 Sep;13(4):221-6. doi: 10.5114/pm.2014.44997. Epub 2014 Sep 9.
- Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE. Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017 Feb 10;35(5):561-564. doi: 10.1200/JCO.2016.71.0947. Epub 2016 Dec 12.
- Kase, K., Wallis, J., & Kase, T. (1996). Clinical Therapeutic Applications of the Kinesio Taping Method. Kinesio Taping Association.
- Johansson K, Albertsson M, Ingvar C, Ekdahl C. Effects of compression bandaging with or without manual lymph drainage treatment in patients with postoperative arm lymphedema. Lymphology. 1999 Sep;32(3):103-10.
- Johansson K, Ohlsson K, Ingvar C, Albertsson M, Ekdahl C. Factors associated with the development of arm lymphedema following breast cancer treatment: a match pair case-control study. Lymphology. 2002 Jun;35(2):59-71.
- Gatt M, Willis S, Leuschner S. A meta-analysis of the effectiveness and safety of kinesiology taping in the management of cancer-related lymphoedema. Eur J Cancer Care (Engl). 2017 Sep;26(5). doi: 10.1111/ecc.12510. Epub 2016 May 11.
- Do J, Jeon J, Kim W. The effects of bandaging with an additional pad and taping on secondary arm lymphedema in a patient after mastectomy. J Phys Ther Sci. 2017 Jul;29(7):1272-1275. doi: 10.1589/jpts.29.1272. Epub 2017 Jul 15.
- Düger, T., Ünal, E., Öksüz, Ç., Yörükan, S., Akel, B. S., Ayhan, Ç., & Leblebicioğlu, A. G. (2006). Kol, omuz ve el sorunları (DASH) anketi Türkçe uyarlamasının güvenirliği ve geçerliği. Fizyoterapi Rehabilitasyon, 17(3), 99-107.
- Basoglu C, Sindel D, Corum M, Oral A. Comparison of complete decongestive therapy and kinesiology taping for unilateral upper limb breast cancer-related lymphedema: A randomized controlled trial. Lymphology. 2021;54(1):41-51.
- Anand, B., Kalra, R., & Sharma, H. (2021). Physiotherapeutic interventions for breast cancer related lymphedema i n women: a review study. Angiol Open Access, 9, 126.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Studienbeginn
Primärer Abschluss (Geschätzt)
Primärer Abschluss
Studienabschluss (Geschätzt)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- 400
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
All data obtained from the assessment scales used in the study will be shared; however, patients' personal information, including names, surnames, and contact details, will be kept confidential. These personal data will only be shared on an individual basis if specifically requested.
Art der unterstützenden IPD-Freigabeinformationen
- STUDIENPROTOKOLL
- ICF
- CSR
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .